AsianScientist (Sep. 9, 2011) – Headquartered in Tokyo, Japan, Mitsui Chemicals, Inc. (MCI), held a ceremony at The Japanese Association in Singapore today to commemorate the opening of the Mitsui Chemicals Singapore R&D Center (MS-R&D), established as part of the company’s fundamental management strategy for globalization.
The Mitsui Chemicals Group has 15 companies in ASEAN countries and India, and positions Singapore as an important production and sales base in its global business.
The Group already has three companies in the country: Mitsui Chemicals Asia Pacific, Ltd., Mitsui Phenols Singapore, Pte, Ltd., and Mitsui Elastomers Singapore, Pte, Ltd.
This April, head office operations for the high performance elastomer TAFMER™, in which MCI holds the world’s top share, were transferred to its subsidiary in Singapore.
Additionally, the government offers many advantages to support relocation of R&D facilities to the country in an effort to become the Asian hub for R&D activity.
In 2006, MCI established a technical center under its regional management company, Mitsui Chemicals Asia Pacific, Ltd., where together with A*STAR, it conducted research on catalysis science and technology.
Through the new MS-R&D, the company targets intensifying its R&D activities, in line with fundamental strategies of the 2011 Mid-Term Business Plan, developing next generation core business, accelerating globalization, and enhancing its business presence in Asia.
——
Source: Mitsui Chemicals, Inc.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.
